Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 31, 2019 08:30 ET | Source: Fluidigm Corporation

Fluidigm Introduces REAP-Seq for Multi-Omic Single-Cell Analysis on the C1

SOUTH SAN FRANCISCO, Calif., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), a leader in mass cytometry and microfluidics technologies, today announced the introduction of a...
January 14, 2019 16:05 ET | Source: Fluidigm Corporation

Fluidigm Announces Conference Call and Webcast of Fourth Quarter and Full Year 2018 Financial Results

SOUTH SAN FRANCISCO, Calif., Jan. 14, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), a leader in mass cytometry and microfluidics technologies, announced today that it will report...
January 08, 2019 08:30 ET | Source: Fluidigm Corporation

Caprion Biosciences Offers Mass Cytometry CRO Services to Advance Biomarker Discovery and Immune Monitoring

SOUTH SAN FRANCISCO, Calif. and MONTREAL, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Caprion Biosciences, a world-leading specialty contract research organization (CRO) laboratory providing state-of-the-art...
December 14, 2018 16:05 ET | Source: Fluidigm Corporation

Fluidigm Announces Closing of Public Offering of 9,372,500 Shares of Common Stock Including Full Exercise of Option to Purchase Additional Shares

SOUTH SAN FRANCISCO, Calif., Dec. 14, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, today announced the closing of its...
December 12, 2018 01:01 ET | Source: Fluidigm Corporation

Fluidigm Announces Pricing of Public Offering of 8,150,000 Shares of Common Stock

SOUTH SAN FRANCISCO, Calif., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, today announced the pricing of an...
December 11, 2018 16:01 ET | Source: Fluidigm Corporation

Fluidigm Announces Commencement of Public Offering of Common Stock

SOUTH SAN FRANCISCO, Calif., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, today announced that it intends to...
November 12, 2018 16:05 ET | Source: Fluidigm Corporation

Fluidigm to Participate in the 30th Annual Piper Jaffray Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, announced today that the company’s...
November 09, 2018 16:05 ET | Source: Fluidigm Corporation

Fluidigm Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that the Compensation Committee of its Board of Directors, which is comprised...
November 08, 2018 08:30 ET | Source: Fluidigm Corporation

Fluidigm Showcases Immuno-Oncology Innovations for Translational and Clinical Research at SITC 2018

A comprehensive suite of innovative immuno-oncology applications to improve the future of cancer care SOUTH SAN FRANCISCO, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation...
November 07, 2018 16:11 ET | Source: Fluidigm Corporation

Fluidigm Recognized as a Company to Watch in 2019

Immuno-oncology innovator receives life science people’s choice award SOUTH SAN FRANCISCO, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- BioInformatics Inc., the leading research and advisory firm...